Key facts
- Five Narrow Lane LP filed SCHEDULE 13G for GT BIOPHARMA, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE (GTBP).
- Disclosed ownership: 10%.
- Date of event: 13 May 2025.
Five Narrow Lane LP - 13 May 2025 SCHEDULE 13G Report for GT BIOPHARMA, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE (GTBP)
- Filing Manager
- Five Narrow Lane LP
- Reporting Manager
- Five Narrow Lane LP
- Symbol
- GTBP
- Shares outstanding
- 2,536,416 shares
- Disclosed Ownership
- 253,388 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 14 May 2025, 09:22:44 UTC
- Date of event
- 13 May 2025
- SEC
- View on sec.gov
Key filing fact
Five Narrow Lane LP disclosed 10% ownership in GT BIOPHARMA, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE (GTBP) on 13 May 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 May 2025, 09:22.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Five Narrow Lane LP | 10% | 253,388 | 253,388 | 0 | /s/ Arie Rabinowitz | Arie Rabinowitz/Managing Member of the General Partner |
CIK / CUSIP context first